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Paradoxical Facilitation of Object Recognition Memory after
Infusion of Scopolamine into Perirhinal Cortex: Implications
for Cholinergic System Function
Boyer D. Winters, Lisa M. Saksida, and Timothy J. Bussey
Department of Experimental Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom
The cholinergic system has long been implicated in learning and memory, yet its specific function remains unclear. In the present study,
we investigated the role of cortical acetylcholine in a rodent model of declarative memory by infusing the cholinergic muscarinic receptor
antagonist scopolamine into the rat perirhinal cortex during different stages (encoding, storage/consolidation, and retrieval) of the
spontaneous object recognition task. Presample infusions of scopolamine significantly impaired object recognition compared with
performance of the same group of rats on saline trials; this result is consistent with previous reports supporting a role for perirhinal
acetylcholine in object information acquisition. Scopolamine infusions directly before the retrieval stage had no discernible effect on
object recognition. However, postsample infusions of scopolamine with sample-to-infusion delays of up to 20 h significantly facilitated
performance relative to postsample saline infusion trials. Additional analysis suggested that the infusion episode could cause retroactive
or proactive interference with the sample object trace and that scopolamine blocked the acquisition of this interfering information,
thereby facilitating recognition memory. This is, to our knowledge, the first example of improved recognition memory after administra-
tion of scopolamine. The overall pattern of results is inconsistent with a direct role for cortical acetylcholine in declarative memory
consolidation or retrieval. Rather, the cholinergic input to the perirhinal cortex may facilitate acquisition by enhancing the cortical
processing of incoming stimulus information.
Key words: acquisition; consolidation; declarative memory; interference; muscarinic; rat
Introduction
The neurotransmitter acetylcholine (ACh) has long been impli-
cated in cognitive functions (Everitt and Robbins, 1997; Sarter
and Bruno, 1997; Bartus, 2000), but the specific contribution of
cortical ACh to learning and memory remains unclear. The na-
ture of the mnemonic effects produced by certain cholinergic
manipulations suggests a role in enhancing cortical information
processing to facilitate acquisition of new material (Chiba et al.,
1995; Bucci et al., 1998; Furey et al., 2000; McGaughy et al., 2005),
a function for cortical ACh that would be consistent with its
broader role in attention (Sarter et al., 2003). Conversely, results
from studies with postacquisition manipulations have suggested
that ACh may be directly involved in memory consolidation.
These findings, however, have been mixed, with some suggesting
that ACh is necessary for consolidation of memory for tasks such
as fear conditioning and inhibitory avoidance (Power et al., 2003)
and others pointing toward a facilitative role for reduced levels of
cortical ACh in declarative memory consolidation (Hasselmo,
1999; Gais and Born, 2004a,b; Hasselmo and McGaughy, 2004).
The correlation between cholinergic system dysfunction and
cognitive impairment in Alzheimer’s disease (AD) has been very
influential in the implication of ACh in learning and memory
functions (Perry et al., 1978; Bartus et al., 1985). The most prom-
inent early cognitive symptom in AD is a disruption in the ability
to acquire new declarative memories (Morris and Kopelman,
1986). Declarative memory has been studied in animals to a large
extent using tests of object recognition memory; indeed, it has
been suggested that object recognition tasks provide a relatively
pure assessment of declarative memory function (Manns et al.,
2000).
A structure known to be crucial for object recognition is the
perirhinal cortex (PRh) (Zola-Morgan et al., 1989; Meunier et al.,
1993; Mumby and Pinel, 1994; Buffalo et al., 1998; Winters et al.,
2004), and recent studies have implicated the cholinergic input to
the PRh in this form of memory (Tang et al., 1997; Warburton et
al., 2003; Abe et al., 2004; Turchi et al., 2005; Winters and Bussey,
2005b). The present study, therefore, examined systematically
the involvement of PRh ACh in the different stages of the spon-
taneous object recognition task (Ennaceur and Delacour, 1988).
Specifically, we tested the effects of transient intra-PRh blockade
of muscarinic cholinergic receptors with scopolamine during
sample presentation (encoding/acquisition), during the choice
phase (retrieval), and during the retention interval (storage/con-
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solidation). We have previously demonstrated involvement of
PRh in these three stages of object recognition memory, and the
pattern of these past results has suggested that the object trace is
consolidated within the PRh by 40 min after the sample presen-
tation (Winters and Bussey, 2005a,c). In the present study, pre-
sample infusions of scopolamine disrupted long-term object rec-
ognition memory, whereas infusions administered during the
retention interval produced a surprising and robust memory fa-
cilitation. These results suggest a direct role for cortical ACh in




The subjects were 108 adult male Lister hooded rats (Harlan Olac, Bic-
ester, UK), weighing 270 –320 g before surgery and housed in pairs in a
room with a 12 h light/dark cycle (lights on at 7:00 P.M.). Different
batches of rats were used for each experiment. The number of rats used in
each experiment was as follows: experiment 1, 27 rats; experiment 2, 27
rats; experiment 3, 32 rats; experiment 4, 12 rats; experiment 5, 10 rats.
All behavioral testing was conducted during the dark phase of the cycle.
During testing, rats were fed 15 g of laboratory chow after daily behav-
ioral sessions to maintain weights at 85–90% of free-feeding body weight.
Water was available ad libitum throughout the experiment. All experi-
mentation was conducted in accordance with the UK Animals (Scientific
Procedures) Act, 1986.
Surgery
For each experiment, all rats were implanted bilaterally with 22-gauge
indwelling guide cannulas according to the following procedure. Before
surgery, all animals were deeply anesthetized by intraperitoneal injection
(60 mg/kg) of sodium pentobarbital (Sagatal; Rhône Mérieux, Essex,
UK) and placed in a stereotaxic frame (David Kopf Instruments, Tu-
junga, CA) with the incisor bar set at 3.2 mm. The scalp was cut and
retracted to expose the skull. Holes were drilled and the guide cannulas
implanted according to the following coordinates, measured relative to
the skull at bregma (Paxinos and Watson, 1997): anteroposterior, 5.5
mm; lateral,  6.6 mm; dorsoventral, 6.5 mm. The ends of the guide
cannulas were, thus, located just dorsal to the main target area. The
cannulas were secured to the skull using four jeweler screws and dental
acrylic. Obdurators cut to extend 1.1 mm beyond the tip of the guide
cannulas and with an outer diameter of 0.36 mm were inserted into the
guides and remained there except during infusions. At the completion of
each surgery, the skin was sutured, and an antibiotic powder (Acramide;
Dales Pharmaceuticals, Skipton, UK) was applied. Animals were allowed
to recover for at least 7 d before the beginning of behavioral testing.
Histology
After behavioral testing, rats were anesthetized by intraperitoneal injec-
tion of 2 ml of Dolethal (Rhône Mérieux) and perfused transcardially
with 100 ml of PBS, pH 7.4, followed by 250 ml of 4% paraformaldehyde
(PFA), pH 7.4. The brains were removed, postfixed in 4% PFA at 4°C for
24 h and then immersed in 25% sucrose in PBS until they sank. Coronal
sections (60 m) were cut on a freezing microtome through the extent of
PRh, and every fifth section was mounted on a gelatin-coated glass slide
and stained with cresyl violet. Slides were examined under a light micro-
scope to verify the cannula placements.
Infusion procedure
For all experiments, rats received bilateral infusions of either physiolog-
ical saline (0.9% sodium chloride, pH 7.0; Aquapharm; Animalcare,
York, UK) or scopolamine hydrobromide trihydrate (10 mg/ml in phys-
iological saline; Sigma, Poole, UK) on a given trial. For all conditions, the
basic procedure was as follows. All infusions took place in a preparation
room separate from the behavioral testing area. Animals were gently
restrained by the experimenter throughout the infusion process. The
obdurators were removed, and the 28-gauge infusion cannulas, which
were cut to extend 1 mm beyond the tip of the guides, were inserted into
the guides. Bilateral infusions were conducted simultaneously using two
1 l Hamilton syringes, which were connected to the infusion cannulas
by propylene tubing. The syringes were driven by a Harvard Apparatus
(Kent, UK) precision syringe pump, which delivered 1 l to each hemi-
sphere over 2 min. The infusion cannulas were left in place for an addi-
tion 1.5 min to allow for diffusion of the infusate. The infusion cannulas
were then removed, and the obdurators replaced before the next phase of
the procedure (for specific experiment parameters, see below, Spontane-
ous object recognition). For all experiments, in each of the two habitua-
tion sessions before the beginning of behavioral testing, rats experienced
a “mock” infusion identical in all aspects to the procedure described
above except that the injection cannulas contained no liquid. This was
done to habituate the animals to the general protocol of the infusion
procedure, including insertion of the infusion cannulas and the sound of
the pump.
Spontaneous object recognition
Spontaneous object recognition was conducted in a Y-shaped apparatus,
as described previously (Winters et al., 2004; Forwood et al., 2005).
Briefly, the Y-shaped apparatus had high, homogeneous white walls con-
structed from Foamalux (Brett Martin, Lancashire, UK) to prevent the
rat from looking out into the room and, thereby, maximize attention to
the object stimuli. The apparatus was raised 30 cm from the floor with
walls 40 cm high. Each arm was 27 cm in length and 10 cm wide. The start
arm contained a guillotine door 18 cm from the rear of the arm. This
provided a start box area within which the rat could be confined at the
start of the sample and choice phases of a given trial. The floor and walls
of the apparatus were wiped down with a dry paper towel between rats,
but otherwise were not cleaned during the experiment. A video camera
was mounted above the apparatus to record all trials. Triplicate copies of
the objects were obtained, which were made of glass, plastic, or metal. For
any given trial, the objects in a pair were composed of the same material
so that they could not readily be distinguished by olfactory cues. The
height of the objects ranged from 5 to 20 cm, and all objects were affixed
to the floor of the apparatus with Blu Tack (Bostik, Stafford, UK) to
prevent them from being displaced during a trial. As far as could be
determined, the objects had no natural significance for the rats, and they
had never been associated with a reinforcer.
General procedure. All rats were habituated in two consecutive daily
sessions in which they were allowed to explore the empty Y-shaped ap-
paratus for 5 min. Before being placed in the apparatus, rats experienced
a mock infusion procedure, as described above. After the mock infusion,
the rats were taken from the preparation area to the testing room and
placed in the start box; the guillotine door was then opened to allow the
rat to explore the main area of the apparatus. When the rat exited the start
box, the guillotine door was lowered to prevent re-entry into this area of
the apparatus. The experimenter did not begin timing the session until
after the rat exited the start box. Testing began 24 h after the second
habituation session. At the start of each day, rats were transported to
holding cages in a room adjacent to the main testing area. The rats re-
mained in these holding cages throughout the day, except when they were
being tested in the Y-shaped apparatus or receiving infusions. When all
behavioral testing for that day was complete, the rats were returned to
their home cages and fed. Rats were given a series of test trials, with a
minimum interval of 24 h between trials. A different object pair was used
for each trial for a given animal, and the order of exposure to object pairs
as well as the designated sample and novel objects for each pair were
counterbalanced within and across groups. The time spent exploring
objects was assessed from video recordings of the sample and choice
phases. Data were collected by scoring exploratory bouts using a personal
computer running a program written in QuickBASIC 4.5. All trials were
run with the experimenter blind to the drug treatment conditions.
Object recognition test. Each trial consisted of two phases. In the sample
phase, two identical objects (A1 and A2) were placed in the Y-shaped
apparatus, one at the end of each exploration arm. The rat was placed in
the start box with the guillotine door lowered. The guillotine door was
then raised to allow the rat into the exploration area of the maze. When
the rat exited the start box, the guillotine door was lowered to prevent
re-entry, and the sample phase began. The time spent exploring the two
objects was scored by an experimenter viewing the rat on a video screen.
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The cumulative duration of exploratory bouts, the beginning and end of
which were indicated by pressing a given key on the computer keyboard,
was calculated by the computer program. Exploration of an object was
defined as directing the nose to the object at a distance of 2 cm and/or
touching it with the nose. The sample phase ended when the rat had
explored the identical objects for a total of 25 s.
At the end of the sample phase, the rat was removed from the Y-shaped
apparatus for the duration of the retention delay, which was 24 h for all
experiments. After the delay, the rat was placed back in the start box of
the Y-shaped apparatus and released into the exploration area for the
choice phase. The Y-shaped apparatus now contained an identical copy
of the sample (familiar) object (A3) in one arm and a new object (B) in
the other. The exploration arms in which the choice objects were placed
were counterbalanced between rats and across trials. The rat was allowed
to explore the objects for 2 min, at the end of which it was removed and
returned to its home cage. The time spent exploring the novel and famil-
iar objects was recorded for the 2 min of the choice phase, but attention
was focused on the first minute, during which object discrimination is
typically greatest. We calculated a discrimination ratio, the proportion of
total exploration time spent exploring the novel object (i.e., the differ-
ence in time spent exploring the novel and familiar objects divided by the
total time spent exploring the objects), for the first minute of the choice
phase on each object recognition trial. This measure takes into account
individual differences in the total amount of exploration time.
Experiment 1. Experiment 1 assessed the effects of intra-PRh infusions
of scopolamine in three groups of rats, whose infusion times corre-
sponded to discrete stages within an object recognition trial. (1) The
presample group (n  10) received infusions, as described above, before
the sample phase. Animals were placed into the Y-shaped apparatus 15
min after the end of the infusion (disengagement of the infusion pump).
(2) The postsample group (n  9) received infusions immediately after
the sample phase. After completion of the requisite 25 s of sample object
exploration, the rat was removed from the apparatus and immediately
transported to the infusion area for the start of intra-PRh infusions. After
infusions, the rats were returned to the holding cages. (3) The prechoice
group (n  8) received infusions before the choice phase. Animals were
placed into the Y-shaped apparatus for choice testing 15 min after the
end of the infusion. All rats were run for a total of four trials, two with
saline infusions and two with scopolamine infusions. The order of drug
and saline infusions was counterbalanced within and between groups.
Experiment 2. Experiment 2 was designed to examine further the ef-
fects of postsample infusions using three groups. (1) The immediate
group (n  10) received infusions of either saline or scopolamine imme-
diately after the sample phase, as described for the postsample group in
experiment 1. (2) The 20 min group (n  9) received infusions 20 min
after the end of the sample phase. At the end of the sample phase, these
rats were transported to the individual holding cages until 20 min had
passed. They were then given intra-PRh infusions of saline or scopol-
amine and returned to the holding cages for the remainder of the testing
day. (3) The 40 min group (n  8) underwent the same procedure as the
20 min group, except that the infusions were delivered at 40 min after the
end of the sample phase. Each of the three groups was tested on four
trials, two with saline and two with scopolamine, and the order of drug
and saline infusions was counterbalanced within and between groups.
Experiment 3. To verify and extend the effects of postsample infu-
sions observed in experiment 2, four groups of animals were tested.
(1) The immediate group (n  8) received infusions of either saline or
scopolamine immediately after the sample phase, as described for the
postsample group in experiment 1. (2) The 8 h group (n  8) received
infusions 8 h after the sample phase. (3) The 16 h group (n  8)
received infusions 16 h after the sample phase. (4) The 20 h group
(n  7) received infusions 20 h after the end of the sample phase, 4 h
before the choice phase. Each group was tested on four trials, two with
saline and two with scopolamine, and the order of drug infusions was
counterbalanced within and between groups.
Experiment 4. Experiment 4 compared the effects of immediate post-
sample infusions of saline or scopolamine to those of a control condition
in which no infusions were delivered. This experiment was designed to
test the hypothesis that the salience of the postsample infusion episode
causes retroactive interference with the sample trace on saline trials and
that postsample scopolamine facilitates performance by blocking this
interference. Each of 12 rats was run for six trials in counterbalanced
order. Each rat experienced two trials in each of the following three
conditions: (1) immediate postsample saline, (2) immediate postsample
scopolamine (the parameters of the saline and scopolamine trials were
identical to those used for the postsample group in experiment 1), and
(3) no infusion (on these trials, rats were removed from the Y-shaped
apparatus immediately after the end of the sample phase and placed back
into the individual holding cages with no additional handling). The no-
infusion condition, thus, eliminated all aspects of handling and arousal
associated with the infusion procedure.
Experiment 5. Experiment 5 compared the effects of 3 h presample
infusions of saline or scopolamine to those of a control condition in
which no infusions were delivered. This experiment was designed to test
whether the detrimental retroactive effects of the infusion episode found
in experiment 4 could also be demonstrated to operate in a proactive
manner and, if so, whether scopolamine could block this impairment.
Each of 10 rats was run for six trials in counterbalanced order. Each rat
experienced two trials in each of the following three conditions: (1) 3 h
presample saline, (2) 3 h presample scopolamine (in the saline and sco-
polamine conditions, infusions were delivered in the usual manner, but
3 h before the start of the sample phase), and (3) no infusion (on these
trials, rats remained in the individual holding cages with no further han-
dling until the sample phase). As in experiment 4, the goal of this condi-
tion was to prevent the handling and arousal associated with the infusion
episode.
Figure 1 illustrates the basic protocols used for each of the five exper-
iments described above.
Data analysis
Group means of three measures taken from object recognition testing
(duration of the sample phase, total exploration time in the choice phase,
and the discrimination ratio) were analyzed for each experiment. Means
from these measures were submitted to two-way ANOVA with repeated
measures for experiments 1–3 (group by drug) and univariate repeated-
measures ANOVAs for experiments 4 and 5. Paired-sample t tests were
used for post hoc analyses of within-subject effects, and Student–New-
man–Keuls was used to analyze between-subject effects. All statistical
analyses were conducted with a significance level of   0.05.
Results
Cannula placements
Rats in all experiments had cannulas implanted bilaterally within
the PRh to allow delivery of drugs. All rats included in the behav-
ioral analyses had guide cannulas located bilaterally with injec-
tion needle tips terminating in PRh near the border between areas
35 and 36 within cortical layers 2–5 (Burwell, 2001). These place-
ments were consistently located between 5.80 and 6.30 mm pos-
terior to bregma (Fig. 2), the approximate midsection of the ros-
tral– caudal extent of the PRh.
Experiment 1: muscarinic receptor blockade during encoding,
storage, and retrieval of object recognition memory
We infused saline or scopolamine into the PRh 15 min before the
sample phase, immediately after the sample phase, or 15 min
before the choice phase to assess the effects of cholinergic mus-
carinic receptor blockade on encoding, storage, and retrieval,
respectively. The total time required to meet the sample object
exploration criterion (25 s cumulative) was analyzed, because a
group difference at this stage of the trial might influence subse-
quent recognition performance. This analysis revealed no signif-
icant effects of group (F(2,24)  1.59), drug (F(1,24)  1.13), or the
group by drug interaction term (F  1). The means (SEM) for
separate conditions were as follows: presample, saline, 88.89 
16.06 s, scopolamine, 89.87  11.29 s; postsample, saline,
116.91  27.14 s, scopolamine, 87.91  7.81 s; prechoice, saline,
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76.49  9.38 s, scopolamine, 70.26  9.58 s. There was also no
significant effect of group (F(2,24)  2.68), drug (F  1), or group
by drug interaction (F  1) on the total amount of time spent by
rats exploring the objects in the choice phase (means  SEM:
presample, saline, 20.61  1.57 s, scopolamine, 20.99  1.43 s;
postsample, saline, 19.09  1.41 s, scopolamine, 16.79  1.98 s;
prechoice, saline, 21.84  1.58 s, scopol-
amine, 19.81  1.94 s). In contrast, intra-
PRh infusions of scopolamine had a signif-
icant effect on object recognition
performance, which was related to the
time at which the infusions were adminis-
tered (Fig. 3); this was reflected in a signif-
icant group by drug interaction effect on
the discrimination ratio scores (F(2,24) 
6.28; p  0.01). Post hoc analysis with sep-
arate paired-sample t tests revealed signif-
icant differences between saline and sco-
polamine trial performance in the
presample (t(9)  2.25; p  0.05) and post-
sample (t(8)  2.58; p  0.05) groups, but
not the prechoice group (t  1). The main
effects of group (F(2,24)  1.08) and drug
(F  1) were, however, not significant.
Figure 3 shows that the performance of the
presample group on scopolamine trials
was significantly worse than on saline tri-
als, whereas the opposite pattern was ob-
served in the postsample group. Thus, pre-
sample injections of scopolamine
impaired object recognition memory, pre-
choice injections had no effect, and post-
sample injections produced a facilitation
of performance.
Experiment 2: additional analysis of
muscarinic receptor blockade
during storage
The results from the presample group in
experiment 1 implicate PRh muscarinic
cholinergic receptors in the encoding stage
of object recognition memory. This find-
ing is consistent with other recent reports
of the effects of presample or pretraining
intra-PRh scopolamine in object recogni-
tion tasks (Tang et al., 1997; Warburton et
al., 2003). Our finding, however, that im-
mediate postsample intra-PRh scopol-
amine facilitated object recognition per-
formance was somewhat surprising. We
have reported previously that transient in-
activation of PRh with lidocaine up to, but
not beyond, 20 min postsample blocked
consolidation in the spontaneous object
recognition task (Winters and Bussey,
2005a), and a similar postsample period of
sensitivity to AMPA and NMDA gluta-
mate receptor blockade also exists (Win-
ters and Bussey, 2005c). We therefore
sought to determine whether the facilita-
tive effect of postsample muscarinic recep-
tor blockade in experiment 1 might be the
result of a direct action of scopolamine on
the consolidation process suggested by these earlier results. Ac-
cordingly, for experiment 2 we conducted infusions of saline or
scopolamine either immediately, 20 min, or 40 min after the
sample phase to determine whether a “window of facilitation”
similar in time course to the detrimental effects of lidocaine and
glutamate receptor antagonists could be observed.
Figure 1. Schematic representation of the infusion protocols for each of the five experiments in the present study. The sample
and choice phases are illustrated for each experiment (Exp.), and the vertical arrows indicate the various infusion times. In each
experiment, a given object-recognition trial consisted of a sample phase in which the rat explored two identical objects, a 24 h
retention delay, and a choice phase in which the rat was presented with a novel object and a triplicate copy of the sample object.
Each vertical arrow indicates a group or condition in which saline and scopolamine were administered in counterbalanced manner
over several trials in a given experiment. For experiments 4 and 5, a vertical arrow with an X represents the no-infusion condition,
which was compared with the effects of immediate postsample or 3 h presample infusions of saline and scopolamine. The
separation of time points in the figure is not to scale.
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Analysis of the sample phase duration revealed no significant
effects of the group (F(2,24)  2.34), drug (F(1,24)  2.79), or
the group by drug interaction (F  1) terms. The means
(SEM) for separate conditions were as follows: immediate, sa-
line, 114.96  12.77 s, scopolamine, 93.83  10.31 s; 20 min,
saline, 87.18  6.47 s, scopolamine, 81.58  15.26 s; 40 min,
saline, 84.93  8.86 s, scopolamine, 76.15  9.33 s. The analysis
of total object exploration in the choice phase revealed significant
group (F(2,24)  10.95; p  0.001) and group by drug (F(2,24) 
3.61; p  0.05) effects, as the immediate group explored less
overall compared with the 20 and 40 min groups (means  SEM:
immediate, saline, 17.48  1.34 s, scopolamine, 13.57  0.85 s; 20
min, saline, 22.29  1.01 s, scopolamine, 21.09  2.05 s; 40 min,
saline, 19.49  1.17 s, scopolamine, 22.08  1.86 s). Importantly,
however, the main effect of drug on overall object exploration in
the choice phase was not significant (F  1). Conversely, there
was a significant drug effect on object recognition performance
(F 1,24)  9.43; p  0.01), as scopolamine improved recognition
memory relative to saline in all infusion groups (Fig. 4). The
group and group by drug terms were, however, not significant
(both F  1). Thus, postsample scopolamine facilitated object
recognition memory, even with a 40 min interval between the end
of the sample phase and the infusion.
Experiment 3: does muscarinic receptor blockade at even
very long postsample intervals facilitate object
recognition memory?
The findings with postsample intra-PRh scopolamine infusions
from experiments 1 and 2 indicate that activation of muscarinic
receptors in PRh during the retention delay can influence object
recognition for stimuli previously encountered. Moreover, the
results of experiment 2 reveal that the facilitative effect of post-
sample intra-PRh scopolamine may result from influencing a
process other than the direct consolidation of the sample object
trace, as previous findings have indicated that the sample trace
may be fully consolidated between 20 and 40 min after the sample
phase in the spontaneous object recognition paradigm (Winters
and Bussey, 2005a,c). In contrast to reports that the detrimental
effects of postsample intra-PRh lidocaine or glutamate receptor
antagonists are no longer seen at a 40 min postsample interval,
intra-PRh scopolamine improved memory for a previously sam-
pled object regardless of whether the infusions were performed
immediately, 20 min, or 40 min postsample in experiment 2. At
the very least, it seems that the effects of scopolamine at the 40
Figure 2. Cannulation of rat PRh. Schematic representation of the infusion needle tip place-
ments from a typical group of animals (experiment 1; presample group; n  10). These place-
ments are representative of needle tip locations in all animals included in the behavioral anal-
yses of the present study. Cannulas were consistently located between 5.80 and 6.30 mm
posterior to bregma. Some needle tips overlap in the figure.
Figure 3. Spontaneous object recognition performance by animals in experiment 1 on trials
in which they received bilateral intra-PRh infusions of scopolamine (Scop) or saline 15 min
before the sample phase (presample), immediately after the sample phase (postsample), or 15
min before the choice phase (prechoice). The retention delay was 24 h. Presample intra-PRh
infusions of scopolamine disrupted object recognition, but postsample infusions facilitated
memory relative to saline trials. Prechoice group performance did not differ between scopol-
amine and saline trials. Data are presented as average discrimination ratio  SEM. *p  0.05.
Figure 4. Spontaneous object recognition performance of the immediate, 20 min, and 40
min postsample infusion groups in experiment 2 on trials in which they received either saline or
scopolamine (Scop) infusions bilaterally into PRh. The retention delay was 24 h. Scopolamine
had an overall facilitating effect on object recognition memory. Data are presented as average
discrimination ratio  SEM.
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min postsample interval do not result from a direct effect on a
consolidation process in PRh. In experiment 3, we therefore
asked how long the postsample infusion of scopolamine could be
delayed and still produce object recognition facilitation. Accord-
ingly, we conducted intra-PRh infusions of saline or scopolamine
immediately, 8, 16, or 20 h after the sample phase.
Although scopolamine did not affect measures of general ob-
ject exploration, intra-PRh infusions produced a significant over-
all improvement in object recognition performance compared
with saline trials (Fig. 5). Analysis of the total time required to
explore the sample objects for 25 s revealed no significant effects
of group (F  1), drug (F  1), or group by drug interaction
(F(3,28)  1.81). The means (SEM) for each group under each
drug condition were as follows: immediate, saline, 80.46  12.81
s, scopolamine, 75.99  7.25 s; 8 h, saline, 99.15  16.29 s, sco-
polamine, 75.97  9.51 s; 16 h, saline, 69.41  6.77 s, scopol-
amine, 87.86  10.79 s; 20 h, saline, 72.66  12.42 s, scopol-
amine, 82.5  14.99 s. The group (F (3,28)  1.48), drug (F  1),
and interaction (F(3,28)  1.34) terms also failed to reach signifi-
cance when the total object exploration time in the choice phase
was analyzed (means  SEM: immediate, saline, 17.93  1.8 s,
scopolamine, 15.17  1.39 s; 8 h, saline, 18.73  1.84 s, scopol-
amine, 20.66  1.74 s; 16 h, saline, 18.29  1.18 s, scopolamine,
18.95  1.73 s; 20 h, saline, 19.73  1.03 s, scopolamine, 20.04 
2.05 s). Analysis of the discrimination ratios for object recogni-
tion, however, revealed significant main effects of drug (F(1,28) 
40.39; p  0.001) and group (F(3,28)  3.8; p  0.05). Post hoc
Newman–Keuls analysis of the latter effect indicated that the 8 h
infusion group performed significantly worse overall than the
immediate and 20 h (both p  0.05), but not the 16 h, infusion
groups. The group by drug interaction term was not significant
(F(3,28)  1.19). Indeed, Figure 5 shows that object recognition
performance with scopolamine infusions was better at all post-
sample infusion intervals when compared with performance on
saline infusion trials.
Experiment 4: does scopolamine block the acquisition of
interfering information?
A notable aspect of the postsample infusion results from experi-
ments 1–3 is the fact that performance on saline trials generally
seemed to be compromised throughout [compare the perfor-
mance of saline-infused animals with control animals in the stud-
ies by Winters et al. (2004) and Forwood et al. (2005)]. It seems
that, rather than directly facilitating memory per se, intra-PRh
scopolamine reversed or blocked some process that interfered
with normal object recognition in the saline infusion conditions.
We hypothesized that the facilitation caused by postsample sco-
polamine could be the result of impaired acquisition of informa-
tion that might interfere retroactively with the sample object
trace. Accordingly, we speculated that arousal associated with the
infusion episode might encourage encoding of information that
could interfere with subsequent object recognition memory per-
formance. According to this view, the scopolamine-induced fa-
cilitation could be because of scopolamine blocking the encoding
of this interfering information in the same way that presample
infusions of scopolamine were seen to disrupt encoding of the
sample object in experiment 1. The hypothesis that the infusion
episode is somehow directly linked to the poor performance on
postsample saline trials is consistent with the findings that saline
performance was generally poor at all postsample infusion times
and the degree of memory amelioration with scopolamine was
equivalent across all postsample conditions. To test this hypoth-
esis, we compared the effects of immediate postsample intra-PRh
infusions of scopolamine or saline with a third condition involv-
ing minimal postsample handling and no infusion. If the infusion
episode does indeed result in some kind of retroactive interfer-
ence that can be blocked by scopolamine, object recognition
memory on trials with no infusions should be as good as it is on
scopolamine trials.
There was no difference between the three conditions in the
time taken to explore the objects in the sample phase (F  1;
means  SEM: saline, 73.46  6.24 s; scopolamine, 88.55 
13.6 s; no infusion, 90.15  12.23 s) or the total exploration time
in the choice phase (F  1; means  SEM: saline, 17.47  1.33 s;
scopolamine, 15.51  1.27 s; no infusion, 16.16  1.24 s). Intra-
PRh infusions of saline, however, significantly disrupted object
recognition memory compared with trials on which animals re-
ceived scopolamine or no infusions (Fig. 6). A univariate
ANOVA on the discrimination ratio scores revealed a significant
Figure 5. Spontaneous object recognition performance of the immediate, 8, 16, and 20 h
postsample infusion groups in experiment 3 on trials in which they received either saline or
scopolamine (Scop) infusions bilaterally into PRh. The retention delay was 24 h. As in experi-
ment 2, scopolamine had an overall facilitating effect on object recognition memory when
infused after the sample phase. Data are presented as average discrimination ratio  SEM.
Figure 6. Spontaneous object recognition performance of rats in experiment 4 on trials in
which they received intra-PRh saline, intra-PRh scopolamine (Scop), or no infusion immediately
after the sample phase. The retention delay was 24 h. Object recognition on saline trials was
disrupted compared with memory performance in the scopolamine and no-infusion conditions.
Data are presented as average discrimination ratio  SEM. ***p  0.001, saline versus sco-
polamine and saline versus no infusion.
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effect of condition (F(2,22)  23.07; p  0.001). Post hoc com-
parisons indicated that performance on saline trials differed
significantly from scopolamine (t(11)  6.53; p  0.001) and
no-infusion (t(11)  5.23; p  0.001) trials, whereas object
recognition on no-infusion trials was similar to that with sco-
polamine (t  1). Thus, immediate postsample saline infu-
sions disrupted object recognition memory, and omitting the
infusion episode, or infusing scopolamine, preserved memory
performance.
Experiment 5: can the infusion episode cause proactive
interference and, if so, can scopolamine block it?
The results of experiment 4 highlight an important practical con-
sideration for experiments in which the effects of postacquisition
manipulations on learning and memory are studied. The dispar-
ate effects of the saline and no-infusion conditions indicate that
the physical act of infusing or injecting drugs can have conse-
quences for memory performance, at least under challenging
conditions such as the 24 h retention delay used in the present
study. Indeed, the results of experiment 4 support our hypothesis
that some aspect of the infusion episode contributed to the poor
performance seen in postsample saline infusion conditions
throughout the present study; merely omitting the infusion was
sufficient to recover object recognition memory to the same lev-
els as those seen on scopolamine trials. Our suggestion is that
postsample scopolamine facilitates object recognition memory
relative to saline by blocking the encoding of interfering informa-
tion at or around the time of the infusion. This hypothesis is
intuitively appealing because it implies that scopolamine may
disrupt or facilitate memory through the same process (blockade
of acquisition) depending on the target information and the con-
text within which the drug is administered. Nonetheless, al-
though it appears that the effects of scopolamine were not caused
by influencing a consolidation process in the PRh, the possibility
remains that scopolamine may have in some other way directly
affected the processing of the sample stimulus to enhance storage
during the retention delay and thereby facilitate recognition. In
experiment 5, we tested the possibility that the same kind of
interference we have hypothesized to be caused by postsample
infusions in the previous studies might also operate proactively to
disrupt object recognition and that this, too, could be blocked by
intra-PRh infusions of scopolamine. Were this to be the case, it
would strongly support our hypothesis that postsample scopol-
amine facilitates recognition memory by blocking acquisition of
interfering information and would be inconsistent with a direct
influence of scopolamine on sample processing, storage, or con-
solidation during the retention interval. We therefore compared
the effects of intra-PRh infusions of saline or scopolamine given
3 h before the sample phase with those of a condition in which no
presample infusions were delivered. We predicted that a 3 h pre-
sample infusion would allow sufficient time for the effects of
scopolamine to dissipate such that there would not be any direct
impairment of acquisition during the sample phase.
The three conditions did not differentially affect the time
taken to explore the sample objects (F  1; means  SEM: saline,
102.91  6.26 s; scopolamine, 92.89  9.58 s; no infusion,
95.17  9.51 s) or the total object exploration time in the choice
phase (F  1; means  SEM: saline, 15.69  1.19 s; scopolamine,
17.15  1.7 s; no infusion, 15.78  1.6 s). The analysis of the
discrimination ratios, however, yielded a significant effect of con-
dition (F(2,18)  11.78; p  0.01) (Figure 7), as object recognition
memory on saline trials was significantly impaired relative to
both scopolamine (t(9)  5; p  0.01) and no-infusion trials
(t(9)  3.41; p  0.01). Performance in the scopolamine and
no-infusion conditions did not differ (t  1). Thus, the infusion
episode can cause interference retroactively and proactively. This
interference is sufficient to disrupt object recognition memory
with a relatively long retention delay (24 h) and can be blocked by
antagonism of muscarinic receptors in PRh, which reverses the
memory deficit.
Discussion
The present results suggest that cortical ACh facilitates acquisi-
tion of new declarative information rather than directly influenc-
ing the storage or consolidation process in the absence of the
to-be-remembered stimulus material. Presample intra-PRh infu-
sions of scopolamine significantly disrupted object recognition
memory with a 24 h retention delay. Prechoice infusions with the
same parameters had no obvious effect on memory retrieval.
Infusions during the retention delay, however, significantly im-
proved object recognition compared with performance on trials
with saline infusions. This facilitation of memory performance by
intra-PRh scopolamine was very reliable and was observed with
even very long sample-to-infusion intervals (20 h). The relatively
poor performance on postsample and 3 h presample saline infu-
sion trials compared with trials with no infusion condition sug-
gests that the act of infusing encourages interference with the
object trace acquired during the sample phase. All of these behav-
ioral effects of scopolamine may, therefore, be mediated by the
same underlying mechanism; specifically, disruption of sample
acquisition may cause subsequent recognition impairment when
scopolamine is administered directly before the sample phase,
whereas scopolamine infusions during the retention delay or 3 h
before the sample phase may block the acquisition of poten-
tially interfering information, thereby improving recognition
memory.
Intra-PRh scopolamine disrupts acquisition, but not
retrieval, of object information
A growing body of evidence indicates that preacquisition admin-
istration of scopolamine disrupts object recognition memory
(Aigner and Mishkin, 1986; Huston and Aggleton, 1987; Enna-
ceur and Meliani, 1992; Dodart et al., 1997; Tang et al., 1997;
Warburton et al., 2003), and permanent cholinergic denervation
of PRh with 192 IgG-saporin in rats (Winters and Bussey, 2005b)
Figure 7. Spontaneous object recognition performance of rats in experiment 5 on trials in
which they received intra-PRh saline, intra-PRh scopolamine (Scop), or no infusion 3 h before
the sample phase. The retention delay was 24 h. Object recognition on saline trials was dis-
rupted compared with memory performance in the scopolamine and no-infusion conditions.
Data are presented as average discrimination ratio  SEM. **p  0.01, saline versus scopol-
amine and saline versus no infusion.
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and ME20.4-saporin in monkeys (Turchi et al., 2005) also im-
pairs visual recognition. Consistent with these findings, presa-
mple, but not prechoice, intra-PRh infusions of scopolamine in
the present study significantly impaired object recognition. These
results indicate a role for PRh ACh in the acquisition, but not
retrieval, of object information. Accordingly, evidence from hu-
man studies suggests that increased cortical ACh can enhance the
selectivity of perceptual processing in the extrastriate cortex dur-
ing encoding in a visual working memory task (Furey et al., 1997,
2000), and scopolamine has been shown to reduce encoding-
related activity in the temporal lobes (including PRh) during
visual delayed matching to sample (Schon et al., 2005). More-
over, reports indicate that direct application of cholinergic agents
can fine-tune the receptive fields of cortical pyramidal cells (Krn-
jevic and Phillis, 1963; Sillito and Kemp, 1983; Murphy and Sil-
lito, 1991; Rasmusson, 2000), and such findings have long been
suggested as evidence for a role of cortical ACh in facilitating
information acquisition, perhaps by amplifying the cortical pro-
cessing of sensory stimuli (Hasselmo and Bower, 1993; Everitt
and Robbins, 1997; Sarter and Bruno, 1997; Weinberger, 2003;
Hasselmo and McGaughy, 2004). Thus, a local effect on stimulus
acquisition within PRh might explain the impairment caused by
presample scopolamine.
Does intra-PRh scopolamine prevent the acquisition of
interfering information?
Unlike its presample effects, postsample infusions of scopol-
amine within the retention delay significantly improved object
recognition memory compared with saline trials, and this was a
highly replicable and robust effect. Indeed, memory facilitation
was found even when the delay between the end of the sample
phase and the infusion was as long as 20 h. We posit that the
facilitative effects of postsample scopolamine on object recogni-
tion were caused by a disruption of new information acquisition
during storage of the sample trace, which minimized retroactive
interference. It has been suggested, however, that low levels of
cortical ACh encourage consolidation (Hasselmo, 1999; Has-
selmo and McGaughy, 2004), and this is a possible alternative
explanation for the postsample effects of scopolamine. However,
we have previously presented data that suggest that consolidation
within PRh is complete within 40 min of the end of the sample
phase (Winters and Bussey, 2005a,c), yet scopolamine facilitated
memory even when it was infused at 8, 16, or 20 h after the sample
presentation. Moreover, the nature of the postsample effects sug-
gests that scopolamine, rather than directly acting on the storage
process to improve memory above and beyond stable control
levels, instead blocked a detrimental outcome of the intradelay
infusion procedure. Thus, performance on postsample saline in-
fusion trials was poor throughout, whereas postsample scopol-
amine maintained performance at normally expected levels. Ac-
cordingly, the results of experiments 4 and 5 revealed that simply
omitting the infusion episode returned performance to the level
of scopolamine infusion trials. Interestingly, this effect was ob-
served with 3 h presample and immediate postsample infusions,
suggesting that the infusion episode leads to interference and that
this interference can act either proactively or retroactively. In
both cases, intra-PRh scopolamine blocked the detrimental ef-
fects of the infusion episode. The fact that 3 h presample infusions
of scopolamine, unlike immediate presample administration, fa-
cilitated memory in an almost identical manner to postsample
infusions is particularly interesting and strongly suggests that the
postsample effects of scopolamine were not caused by a direct
action on the consolidation, or indeed any other processing, of
the sample object trace. These results are consistent with reports
of normally amnesia-inducing drugs (e.g., alcohol, benzodiaz-
epines) causing counterintuitive memory facilitation when they
are administered after the acquisition of new to-be-remembered
information (Wixted, 2004), and the interpretation of such find-
ings in terms of attenuation of interfering information is similar
to that suggested above.
The exact nature of the proposed interference produced by
infusions remains unclear. It is possible that stress caused by the
handling involved in the infusion procedure played a role in the
deficit seen with postsample saline infusions. However, gentle
handing was used during infusions, and rats were habituated to
the procedure and did not ever appear to be stressed during in-
fusions. Furthermore, a recent report indicates that, if anything,
increased levels of glucocorticoids caused by stress shortly after
the sample phase should improve object recognition memory
(Okuda et al., 2004), which was not the case after saline infusions.
Conceivably, infusions may produce interference by causing a
general arousal in the animal that leads to the enhanced encoding
of sensory information. It may be this sensory information that
leads to interference with the sample trace. It is interesting to note
that performance with postsample saline infusions in the present
study was substantially poorer than in our previous studies (Win-
ters and Bussey, 2005a,c). The current series of experiments is the
first in which we have used a 24 h retention delay to assess the
effects of postsample infusions. Previously, the longest delay we
have used was 3 h. The interference effect observed in the present
study might only exert a significant influence on memory when
the retention delay is relatively long. It would, therefore, be inter-
esting to assess the effects of the present manipulations with
shorter retention delays for comparison with the present results.
On the basis of the present findings, however, regardless of the
effects of postsample saline, we would predict that scopolamine
would not disrupt memory consolidation with a shorter (e.g.,
3 h) retention delay.
There is growing evidence that ACh in PRh may directly in-
fluence synaptic plasticity related to object recognition memory
(Massey et al., 2001; Bashir, 2003; Warburton et al., 2003), and
such findings suggest a role for PRh ACh in consolidation and
storage mechanisms. It would seem, however, that any effects of
ACh on synaptic plasticity must occur in the very early stages of
stimulus processing, because immediate postsample administra-
tion of scopolamine does not consistently disrupt object recog-
nition memory (Aigner et al., 1991; Warburton et al., 2003) and,
in fact, facilitated performance in the present study. This result
contrasts with our previous findings that have indicated a role for
other aspects of PRh transmission in object trace consolidation
by showing that immediate postsample infusions of lidocaine or
glutamate receptor antagonists severely impair object recogni-
tion memory (Winters and Bussey, 2005a,c) and argues strongly
against the idea that scopolamine’s effects were caused by a direct
action on the consolidation process. It is possible, however, that
an ACh-mediated enhancement of stimulus encoding and acqui-
sition could increase the likelihood of successful consolidation
and subsequent trace storage, augmenting any plastic changes
associated with the acquisition episode. The present pattern of
results, however, suggests that the primary effect of cortical ACh
in declarative memory acquisition likely occurs when the stimu-
lus material is present.
In contrast to the present findings, many previous studies
have indicated that posttraining administration of cholinergic
agents appear to affect memory consolidation (Power et al.,
2003); for example, posttraining manipulations that reduce cho-
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linergic system efficacy disrupt memory in tasks such as fear con-
ditioning, inhibitory avoidance, and conditioned place prefer-
ence (Rudy, 1996; Bianchin et al., 1999; Power and McGaugh,
2002; Schroeder and Packard, 2002), whereas posttraining ad-
ministration of muscarinic receptor agonists has been reported to
improve memory in such tasks (Vazdarjanova and McGaugh,
1999; Farr et al., 2000). It is interesting to note that the vast
majority of these effects are found in tasks that are thought to tax
“emotional” memory and, therefore, are highly influenced by the
amygdala (Power et al., 2003). Such results sit in stark contrast to
our present findings suggesting an adverse effect of increased
postacquisition ACh on object recognition, which is thought to
tax declarative memory. This pattern indicates possibly different
roles for ACh in amygdala-mediated emotional learning and de-
clarative memory. Indeed, Gais and Born (2004a) have shown,
consistent with recent suggestions by Hasselmo et al. (2004), that
increasing ACh levels with physostigmine prevents the facilitative
effects of postlearning sleep on declarative memory in humans;
although it is unclear whether this effect was caused by similar
mechanisms to those suggested by the present results, it nonethe-
less provides further indication that, particularly in the case of
declarative memory, posttraining cortical ACh may not play a
direct role in memory consolidation and can even be detrimental
to memory.
The above discussion highlights a potentially important as-
pect of the role of ACh in learning and memory. There is strong
evidence for a direct role for ACh in the consolidation of emo-
tional associations such as those formed in fear conditioning, and
this function of ACh may be closely linked to the involvement of
the amygdala in such forms of learning and memory [but see
Young et al. (1995), in which posttraining systemic administra-
tion of scopolamine facilitated fear conditioning to a tone. Learn-
ing about the discrete tone stimulus may have been interfered
with by the effects of immediate posttraining injections, and sco-
polamine may have blocked this interference to facilitate memory
by a process similar to the one we posit to explain the present
results]. The present findings and others indicate that, although
cortical ACh is vital for new information acquisition, it is not
required for consolidation of declarative memory. Thus, it may
be that, depending on the nature of the memory and the specific
brain regions involved, different mechanisms mediate consolida-
tion, and not all such mechanisms require ACh.
Conclusion
The findings of the present study indicate that disruption of cho-
linergic function in PRh can impair or facilitate object recogni-
tion memory depending on when this disruption takes place. We
propose that a single underlying mechanism, impaired acquisi-
tion of new information, can explain these results. The pattern of
presample and postsample effects together is inconsistent with a
direct role for cortical ACh in declarative memory consolidation
or other postsample stimulus processing. Nonetheless, it is likely
that consolidation and storage processes are influenced by the
direct enhancement by ACh of cortical information processing
during acquisition.
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